Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease
Yumei Liu, Jing Wang, Fangbo Ning, Guojun Wang, Anmu Xie · 2024
Read Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease by Yumei Liu, Jing Wang, Fangbo Ning, Guojun Wang, Anmu Xie (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11647050.txt.
Description
Yumei Liu and co-authors test a spinal fluid protein as a sign of mind decline in Parkinson's disease, in a 2024 study. The protein is made in brain support cells and may flag decline. Parkinson's has motor subtypes, from tremor led to gait led, and each may need its own sign to track its course.
The study held 216 patients from a large markers project, sorted by motor subtype. Higher base levels of the protein linked to faster loss of memory for events in the tremor led group. Higher base levels also raised the risk of mild mind impairment over four years in patients whose minds were normal at start. The sign looks most useful in that subtype.
Catalog record
| CREATOR | Yumei Liu, Jing Wang, Fangbo Ning, Guojun Wang, Anmu Xie |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |